KMS Medisurgi Ltd (KMSMEDI) — shareholding pattern, promoter holding, financials and share price
About KMS Medisurgi Ltd (KMSMEDI)
KMS Medisurgi Ltd operates in the Medical Equipment & Supplies industry, within the Healthcare sector. It trades on the NSE as KMSMEDI and on the BSE under scrip code 540468. Its ISIN is INE870V01014.
Incorporated in 2016, KMS Medisurgi Ltd operates in the manufacturing of Surgical Equipment. [1]
KMS Medisurgi Limited is a leading manufacturer and distributor of surgical equipment and medical devices in India. The company specializes in coating various substrates and has a strong focus on ethical marketing.
A pivotal player in introducing global technological advancements to the Indian healthcare market, KMS Medisurgi serves as exclusive distributor for world-renowned surgical manufacturers in India.
Listed peers in Medical Equipment & Supplies: Royal Sense Ltd, Shree Pacetronix Ltd, Amkay Products Ltd, GKB Ophthalmics Ltd, Centenial Surgical Suture Ltd, Galaxy Medicare Ltd.
Valuation & Returns
At ₹133 a share, KMS Medisurgi Ltd (KMSMEDI) was valued at a price-to-earnings ratio of 179.46x against an industry P/E of 44.11x and a price-to-book of 5.27x on a book value of ₹25.18 per share. Solomo computes return on equity of 2.95% and return on capital employed of 4.81% from filed results.
- P/E
- 179.46x
- Industry P/E
- 44.11x
- P/B
- 5.27x
- EPS (TTM)
- ₹0.74
- Book value / share
- ₹25.18
- ROE
- 2.95%
- ROCE
- 4.81%
- ROA
- 2.27%
- Debt / equity
- 0.09x
- Dividend yield
- 0.04%
- EBITDA margin
- 7.45%
- 52-week range
- ₹120.5 – ₹132.8
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, KMS Medisurgi Ltd (KMSMEDI) reported revenue of ₹12.21 crore, net profit of ₹0.25 crore and earnings per share of ₹0.76. That compares with revenue of ₹13.94 crore and net profit of ₹0.44 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹5.59 crore and net profit ₹0.01 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 10.32 | 11.03 | 13.88 | 13.94 | 12.21 |
| Net profit (₹ cr) | 0.22 | 0.57 | 0.45 | 0.44 | 0.25 |
| EPS (₹) | 0.67 | 1.73 | 1.36 | 1.33 | 0.76 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 5.77% | 6.15% | 10.55% | 0.43% |
| Profit growth | 13.85% | 31.38% | 26.90% | -2.22% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 74.42% of KMS Medisurgi Ltd (KMSMEDI) (unchanged from the previous quarter). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2017.
Largest disclosed public shareholders in Jun 2026: YAGNESH MANAHARLAL JOSHI 5.82%, LALBAHADUR RUDRAMANI MISHRA 2.3%, VIMLA M SHAH 1.67%, ASHOK BABUBHAI LADE 1.27%, KINDLE BROKING PRIVATE LIMITED 1.21%, SHRENIK PRAFULCHANDRA SANGHVI 1.09%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 74.42% | - | - | - | 25.58% |
| Mar 2026 | 74.42% | - | - | - | 25.58% |
| Dec 2025 | 74.42% | - | - | - | 25.58% |
| Sep 2025 | 74.42% | - | - | - | 25.58% |
| Jun 2025 | 74.42% | - | - | - | 25.58% |
| Mar 2025 | 74.42% | - | - | - | 25.58% |
| Dec 2024 | 74.42% | - | - | - | 25.58% |
| Sep 2024 | 74.42% | - | - | - | 25.58% |